MITRA.BR Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 11:35):

Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Europe and internationally...

Stats
Today's Volume	113 992
Average Volume	386 246
Market Cap	15.20M
EPS	€0 ( 2024-03-08 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-0.160
ATR14	€0.00200 (0.91%)

Mithra Pharmaceuticals SA Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Mithra Pharmaceuticals SA Financials

Annual	2023
Revenue:	€40.16M
Gross Profit:	€5.99M (14.92 %)
EPS:	€-2.51

Q4	2023
Revenue:	€33.12M
Gross Profit:	€13.54M (40.88 %)
EPS:	€-1.780

Q2	2023
Revenue:	€7.04M
Gross Profit:	€-7.55M (-107.32 %)
EPS:	€-0.880

Q4	2022
Revenue:	€55.64M
Gross Profit:	€36.99M (66.48 %)
EPS:	€-0.520

Financial Reports:

No articles found.

Mithra Pharmaceuticals SA

Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Europe and internationally. Its development candidates include Estelle, which has completed phase III clinical trial, which is a combined oral contraceptive; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a solution for treating menopause and osteoporosis; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it offers NEXTSTELLIS, an oral contraceptive pill. In addition, the company provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. Mithra Pharmaceuticals SA was founded in 1999 and is headquartered in Liège, Belgium.